X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29) 29
index medicus (28) 28
female (25) 25
oncology (24) 24
middle aged (21) 21
aged (19) 19
chemotherapy (18) 18
adult (17) 17
breast cancer (17) 17
cancer (16) 16
antineoplastic combined chemotherapy protocols - therapeutic use (13) 13
male (13) 13
breast neoplasms - drug therapy (12) 12
quality of life (12) 12
postmenopausal women (11) 11
treatment outcome (10) 10
aged, 80 and over (9) 9
analysis (9) 9
breast neoplasms - pathology (9) 9
cancer therapies (9) 9
care and treatment (9) 9
research (9) 9
capecitabine (8) 8
colorectal cancer (8) 8
adjuvant treatment (7) 7
aromatase inhibitors (7) 7
clinical trials (7) 7
double-blind (7) 7
journal article (7) 7
medicine, general & internal (7) 7
survival (7) 7
tamoxifen (7) 7
therapy (7) 7
anastrozole (6) 6
bevacizumab (6) 6
chemotherapy, adjuvant (6) 6
combination (6) 6
fluorouracil (6) 6
letrozole (6) 6
metastasis (6) 6
paclitaxel (6) 6
patients (6) 6
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
cancer patients (5) 5
disease-free survival (5) 5
drug administration schedule (5) 5
endocrine therapy (5) 5
exemestane (5) 5
fatigue (5) 5
internal medicine (5) 5
medicine & public health (5) 5
multicenter (5) 5
neoplasm staging (5) 5
oncology, experimental (5) 5
palbociclib (5) 5
prognosis (5) 5
studies (5) 5
survivors (5) 5
abridged index medicus (4) 4
advanced breast cancer (4) 4
breast neoplasms - metabolism (4) 4
colorectal neoplasms - drug therapy (4) 4
development and progression (4) 4
drug dosages (4) 4
drug therapy (4) 4
esophageal cancer (4) 4
exercise (4) 4
hematology (4) 4
hematology, oncology and palliative medicine (4) 4
irinotecan (4) 4
kaplan-meier estimate (4) 4
metastatic breast cancer (4) 4
multicenter study (4) 4
neoadjuvant chemoradiotherapy (4) 4
neoplasm metastasis (4) 4
netherlands (4) 4
oxaliplatin (4) 4
physical fitness (4) 4
prospective studies (4) 4
randomized controlled trial (4) 4
surgery (4) 4
survival analysis (4) 4
toxicity (4) 4
trial (4) 4
women (4) 4
1st-line treatment (3) 3
activities of daily living (3) 3
adjuvant (3) 3
adjuvant endocrine therapy (3) 3
angiogenesis inhibitors (3) 3
antibodies, monoclonal, humanized (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
aromatase inhibitor (3) 3
bone neoplasms - drug therapy (3) 3
bone neoplasms - secondary (3) 3
colon cancer (3) 3
combination chemotherapy (3) 3
confidence intervals (3) 3
deoxycytidine - administration & dosage (3) 3
deoxycytidine - analogs & derivatives (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2015, Volume 385, Issue 9980, pp. 1843 - 1852
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2009, Volume 360, Issue 6, pp. 563 - 572
Capecitabine, oxaliplatin, and bevacizumab are standard treatment for metastatic colorectal cancer. This trial tested whether adding cetuximab to this... 
CAPECITABINE | GROWTH-FACTOR RECEPTOR | MEDICINE, GENERAL & INTERNAL | LEUCOVORIN | PLUS OXALIPLATIN | FINAL REPORT | PHASE-III | COMBINATION CHEMOTHERAPY | IRINOTECAN | 1ST-LINE THERAPY | FLUOROURACIL | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Capecitabine | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Antibodies, Monoclonal, Humanized | Organoplatinum Compounds - administration & dosage | Receptor, Epidermal Growth Factor - metabolism | Fluorouracil - administration & dosage | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Treatment Failure | Aged, 80 and over | Adult | Female | Cetuximab | Receptor, Epidermal Growth Factor - immunology | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Proto-Oncogene Proteins - genetics | Disease-Free Survival | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quality of Life | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Mutation | Colorectal Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Care and treatment | Chemotherapy | Usage | Health aspects | Colorectal cancer | Cancer | Clinical trials | Cancer therapies | Medical treatment | Committees | Index Medicus | Abridged Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2007, Volume 370, Issue 9582, pp. 135 - 142
Journal Article
International Journal of Cancer, ISSN 0020-7136, 01/2019, Volume 145, Issue 1, pp. 274 - 283
Journal Article
Journal Article
Medicine and Science in Sports and Exercise, ISSN 0195-9131, 05/2016, Volume 48, Issue 5, pp. 767–775 - 775
Journal Article
Cancer, ISSN 0008-543X, 01/2016, Volume 122, Issue 19, pp. 2961 - 2970
Journal Article
Journal Article
by Cats, Annemieke and Jansen, Rob LH and Jansen, Edwin P M and van Grieken, Nicole C T and Sikorska, Karolina and Lind, Pehr and Nordsmark, Marianne and Meershoek-Klein Kranenbarg, Elma and Boot, Henk and Trip, Anouk K and Swellengrebel, H A Maurits and van Laarhoven, Hanneke W M and Putter, Hein and van Sandick, Johanna W and van Berge Henegouwen, Mark I and Hartgrink, Henk H and van Tinteren, Harm and van de Velde, Cornelis J H and Verheij, Marcel and Van Coevorden, Frits and Vanhoutvin, Steven and Hulshof, Maarten CCM and Loosveld, Olaf JL and Ten Tije, A (Bert) Jan and Erdkamp, Frans LG and Warmerdam, Fabienne ARM and Van der Peet, Donald L and Verheul, Henk MW and Boerma, Djamila and Los, Maartje and Slot, Annerie and Houtsma, Danny and Portielje, Johanna EA and Blaisse, Reinoud JB and Spillenaar Bilgen, Ernst Jan and Polée, Marco B and Geenen, Maud M and Braak, Jeffrey PBM and Neelis, Karen J and Slingerland, Marije and Buijsen, Jeroen and Beeker, Aart and Eijsbouts, Quirijn AJ and Van Riel, Johanna MGH and Rozema, Tom and Van Spronsen, Dick Johan and Meerum Terwogt, Jetske M and Tanis, Bea C and Van der Torren-Conze, Adelheid ME and Van Hilligersberg, Richard and Koopman, Miriam and Den Boer, Marien O and Creemers, Geert-Jan and Van der Sangen, Maurice and Rentinck, Marjolein EM and Van den Berg, H Pieter and Jonkers, Ge JPM and Grootenboers, Diane and Vulink, Annelie JE and Hovenga, Sjoerd and Van der Mijle, Huub CJ and Baars, Arnold and Haringhuizen, Annebeth W and Appels, Marije IE and Rietbroek, Ron C and Hendriksen, Ellen M and Legdeur, Marie-Cecile JC and Ten Bokkel Huinink, Daan and Van Dobbenburgh, O Aart and Smit, Jitty M and Van Bochove, Aart and Veldhuis, Gerrit-Jan and Muller, Erik W and Bonenkamp, J (Han) J and Braam, Pètra M and De Boer, Jaap and Van Halteren, Henk K and Valster, Fransje AA and Imholz, Alex LT and Van Dijk, Marjan A and Van der Gaast, Ate and Otten, J (Hans)-Martin MB and Ceha, Heleen M and Glimelius, Bengt and Lagerbäck, Cecillia and Perman, Mats and Johnsson, Anders and Borg, David and Nielsen, Niels H and Piwowar, Andrzej and Elmlund, Mattias and Hörberg, Helene and Edlund, Per and Johansson, Bengt and Flygare, Petra and Jespersen, Marie Louise and CRITICS Investigators and CRITICS investigators
The Lancet Oncology, ISSN 1470-2045, 05/2018, Volume 19, Issue 5, pp. 616 - 628
Both perioperative chemotherapy and postoperative chemoradiotherapy improve survival in patients with resectable gastric cancer from Europe and North America.... 
CAPECITABINE | PERIOPERATIVE CHEMOTHERAPY | DOSE-ESCALATION | NODAL DISSECTION | CISPLATIN | ONCOLOGY | I-II | ADENOCARCINOMA | POSTOPERATIVE CHEMORADIOTHERAPY | FLUOROURACIL | III TRIAL | Neoadjuvant therapy | Chemotherapy | Stomach cancer | Analysis | Cancer
Journal Article
Breast Cancer Research and Treatment, ISSN 0167-6806, 11/2018, Volume 172, Issue 2, pp. 413 - 423
Journal Article
Journal Article